Who is sponsoring NCT05874440?

NCT05874440 is sponsored by Sohag University.

What drugs are being tested in NCT05874440?

Interventions in NCT05874440: Tenofovir Disoproxil Fumarate and Entcavir.

What condition does NCT05874440 study?

NCT05874440 studies Chronic Hepatitis b Patients.

Is NCT05874440 still recruiting?

NCT05874440 is currently status unknown. Last updated 24 May 2023.

Last reviewed 2023-05-24 · How we verify

NCT05874440

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper Egypt

Status unknown Last updated 24 May 2023

What this trial tests

trial testing Tenofovir Disoproxil Fumarate and Entcavir in Chronic Hepatitis b Patients in 100 participants. Status unknown.

Timeline

15 April 2023

Primary endpoint
30 April 2024

30 April 2024

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 April 2023
Primary completion	30 April 2024
Estimated completion	30 April 2024
Sites	1 location across Egypt

Drugs / interventions tested

Tenofovir Disoproxil Fumarate and Entcavir — full drug profile →

Conditions studied

Chronic Hepatitis b Patients — all drugs for Chronic Hepatitis b Patients →

Sponsor

Sohag University

Who can join

18 and older, any sex, with Chronic Hepatitis b Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic hepatitis B (CHB) is one of the major causes of chronic liver diseases worldwide. Around 296 million people were living with chronic hepatitis B infection, with 1.5 million new infections each year and more than 820 thousand people die because of hepatitis B virus (HBV) related complications

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05874440 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 24 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05874440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing